Therefore, this study aims to investigate whether tacrolimus modulates the expression of key TGF-β-related genes and miRNAs in LPS-stimulated H-RPE cells, providing novel insights into its potential as a therapeutic agent for inflammatory and fibrotic retinal diseases. The gene discussed is TGFB1; the disease is Abnormal retinal morphology.